Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Annals of Hepatology|August 11, 2015
Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast MexicoLinda E Muñoz-Espinosa, Maria E Trujillo-Trujillo, Roberto F Martínez-Macías, et al.
NPJ Regenerative Medicine|March 21, 2025
A novel therapy to ameliorate nitrogen mustard-induced limbal stem cell deficiency using lipoprotein-like nanoparticlesElif Kayaalp Nalbant, Timothy J Feliciano, Aliakbar Mohammadlou, et al.
Revista De Gastroenterologia De Mexico (English)|May 21, 2025
Good clinical practice recommendations for the diagnosis and treatment of functional dyspepsia: An expert review from the Asociación Mexicana de GastroenterologíaR I Carmona-Sánchez, G Vázquez-Elizondo, M C Rodríguez-Leal, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Plos One|October 21, 2017
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodentMichele J Pachanski, Melissa E Kirkland, Daniel T Kosinski, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Structure-Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMsHelen Y Chen, Christopher W Plummer, Dong Xiao, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Design and Synthesis of Novel, Selective GPR40 AgoPAMsChristopher W Plummer, Matthew J Clements, Helen Chen, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2019
Design, synthesis and biological evaluation of indane derived GPR40 agoPAMsBarbara Pio, Harry R Chobanian, Yan Guo, et al.
Pageof 25